Safety and Efficacy of Baricitinib in Patients Receiving Conventional Synthetic Disease-Modifying Antirheumatic Drugs or Corticosteroids

Safety and Efficacy of Baricitinib in Patients Receiving Conventional Synthetic Disease-Modifying Antirheumatic Drugs or Corticosteroids

Abstract Introduction This study assessed if concomitant use of conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) or corticosteroids altered the response or safety outcomes to baricitinib in rheumatoid arthritis (RA) patients. Methods Patients with ≥ 6 swollen/tender joints and...

Full description

Bibliographic Details
Main Authors: Ronald van Vollenhoven, Cameron Helt, Vipin Arora, Jinglin Zhong, Ana Pinto Correia, Inma de la Torre, David Muram
Format: Article
Language:English
Published: Adis, Springer Healthcare 2018-10-01
Series:Rheumatology and Therapy
Subjects:
Corticosteroids
DMARDs
Rheumatoid arthritis
Online Access:http://link.springer.com/article/10.1007/s40744-018-0128-0

Internet

http://link.springer.com/article/10.1007/s40744-018-0128-0

Similar Items